期刊名称：CURRENT MEDICAL IMAGING REVIEWS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims & Scope
Current Medical Imaging Reviews publishes frontier reviews on all the latest advances on medical imaging. All relevant areas are covered by the journal, including advances in the diagnosis, instrumentation and therapeutic applications related to all modern medical imaging techniques.
The journal's aim is to publish the highest quality review articles dedicated to research in the field. The journal is essential reading for all clinicians and researchers involved in medical imaging and diagnosis.
Instructions to Authors
|
Instructions for Authors
Online Manuscript Submission: Manuscripts must only be submitted online to the Bentham Science Editorial Office. It is preferable that authors first send an abstract to the editor, prior to submitting the full manuscript. The submitted abstract should outline the intended contents and coverage of the article. Abstracts may be sent either by e-mail to the editorial office at cmir@bentham.org or alternatively by the Internet at www.bentham.org/onlAbsSub.htm
After approval of your abstract by the editor, you may submit your full manuscript either by e-mail (file size restricted) or by online submission.
For short review manuscripts these may be submitted as an e-mail attachment (maximum file size 512 KB) to the editorial office at cmir@bentham.org
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org or by FTP submission at www.bentham-ftp.org
For all online submissions, please provide your complete manuscript in the form of a single zipped folder containing soft copies of all the material (main text in MS word format, figures / illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files, while a PDF version of the entire manuscript must also be included with all the figures / illustrations / tables / chemical structures etc. embedded in the text exactly in the manner as they should appear in print.
Authors are required to proofread the PDF version of their manuscript before submission. The Publishers will not be responsible for any error occurring in the manuscript in this regard.
Manuscript Length: There is no limit on the number of pages that may be submitted, however, page lengths can vary for mini-reviews of up to 12 journal pages and for longer reviews up to 30 journal pages. A printed journal page is ca. 900 words (excluding diagrams and figures).
Manuscript Organization: The manuscript should be divided as: Title page, abstract and the main text. The text may be subdivided further according to the areas to be discussed. The Acknowledgements (if any) and Reference sections must then follow.
Conflict of Interest: Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest.
Title Page: The first page should contain the title, the author's full names, institutional affiliations and location, with an asterisk in front of the name of the principal author. The corresponding author should be designated and their full address, business telephone and fax numbers and e-mail address must be stated to receive correspondence and galley proofs.
Abstract: The abstract should not exceed 200 words and should condense the essential features of the review article.
Key Words: Authors must supply up to six key words along with their manuscript.
Text: The main text should begin on a separate page and it may be subdivided into separate sections. The reference numbers should be given in square brackets in the text. Acknowledgements should be kept to a minimum.
Tables:
- Data Tables should be submitted in Microsoft Excel or in Microsoft Word table format.
- Each table should include a title/caption explaining what the table shows. Detailed legends may then follow.
- Tables should be given on separate pages with indications on the left hand margin to the text, as to the appropriate placement of the tables.
- Tables should not contain vertical rules.
- Columns and rows of data should be made visibly distinct by ensuring the borders of each cell display as black lines.
- Tables should be numbered consecutively in order of their citation in the body of the text, with Arabic numerals.
- If a reference is cited in both the table and text, insert a lettered footnote in the table to refer to the numbered reference in the text.
- Tabular data provided as additional files can be submitted as an Excel spreadsheet.
Figures / Illustrations:
All authors must strictly follow the guidelines below for preparing illustrations for publication in Current Medical Imaging Reviews.
Editorial Requirements:
The quality of the illustrations printed in the journal largely depends on the quality of the figures/illustration provided by the author. In preparing artwork or graphics for publication, keep in mind the following points.
- Submit the original artwork or a photographic print of the original for publication.
- Do not submit photocopies. (Hardcopy submission requirement).
- Illustrations should be provided as separate files, not embedded in the text. (Hardcopy submission requirement).
- Remove all color from graphics except for those illustrations (Greyscale), which are intended to be printed in color.
- Good quality of hardcopy originals are a requirement.
- Figures should be referred to as 揊ig. (1)? 揊ig. (2)?etc. in the text with figure numbers in bold within round bracket.
- Revised manuscripts should contain a complete set of artwork and photographs.
Technical Details:
- Figures should be provided on high quality, white, smooth opaque paper. (Hardcopy requirement).
Format & Resolution:
- The following file formats can be accepted. (Preference in order of appearance): PDF, TIFF, JPEG, GIF.
- Illustrations must fit a single or double column format on the journal page, according to the following guideline below:
|
HEIGHT |
WIDTH |
|
SINGLE COLUMN |
24 cm (max) |
8.5 cm (max) |
|
DOUBLE COLUMN |
24 cm (max) |
18 cm (max) |
- Whenever possible, submit graphics that do not have to be reduced to fit the standard figure size.
- Use the best resolution available (hardcopy submission requirement). For online submission the maximum resolution is 300 dpi.
- Avoid textures and shadings giving a three-dimensional effect to the illustration.
- Symbols and lettering in the illustration should be of similar size.
- Smaller lettering is used.
- Font: Times New Roman or Helvetica is preferable. Font size: 10pt (maximum).
- Line drawings should have clear and sharp lines and should be of uniform density. Moreover, lines should be continuous without any breaks.
- Do not use lines thinner than 1 point.
Color Figures / Illustrations:
Photographs:
Submit high-contrast prints that are of single- or double-column width so that they will not have to be reduced when printed. Negatives are not acceptable. However, in case of hardcopy submission, color illustrations and plates can be published from 35 mm color slides.
Chemical Structures: Chemical structures must be prepared according to the guidelines below.
Structures should be prepared using a suitable drawing program e.g. ChemDraw and provided as separate file, submitted both on disk and in printed formats.
Numbers in bold should identify all chemical structure. If a name is also used to describe the compound, the associated number in bold should be in parenthesis, e.g. 揷ompound (1)?
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120?/P>
Bond spacing 18% of width
Fixed length 14.4 pt (0.500cm, 0.2in)
Bold width 2.0 pt (0.071cm, 0.0278in)
Line width 0.6 pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Harsh spacing 2.5 pt (0.088cm, 0.0347in)
Text settings:
Font Times New Roman / Helvetica
Size 10pt
Under the Preference Choose:
Units points
Tolerances 3 pixels
Under Page Setup Use:
Paper US letter
Scale 100%
References: References should be numbered sequentially [in square brackets] in the text and listed in the same numerical order in the reference section.
All references must be complete and accurate. Online citations should include the date of access. Journal titles should conform to the present Index Medicus abbreviations. It is necessary to list all authors if the total number of authors is 6 or less and for more than 6 authors use 3 authors and then et al. References should be listed in the following Vancouver style:
Typical Paper Reference: Boehm M, Nabel EG. Angiotensin-converting enzyme 2-a new cardiac regulator. N Engl J Med 2002; 347: 1795-7.
SoRelle R. Long reach of the N-terminal of B-type natriuretic peptide. Circulation 2002; 106: 9059-63.
Typical Chapter Reference: Stevenson WG, Friedman PL. In: Hennekens CH Ed, Clinical trials in cardiovascular disease. Philadelphia, WB Saunders Co. 1999; 217-30.
Abstracts, unpublished data and personal communications (which can only be included if prior permission has been obtained) should not be given in the reference section but they may be mentioned in the text and details provided as footnotes.
Manuscript Submission: Two copies of the manuscript must accompany the original along with the soft copy of the manuscript on a computer floppy disk(s) in MS Word file format (or created in any other well-known word processing software) should be submitted. To achieve rapid publication authors are encouraged to e-mail or fax their submission to the appropriate editorial office (see above) at the same time that they mail the manuscript. For even faster publication, authors are encouraged to submit their entire manuscript via Bentham抯 online submission service (see below). Authors must provide their full address, telephone and Fax numbers with E-Mail address with all submissions.
For expedient and speedy reviewing of author's manuscripts, authors are strongly advised to include the PDF file of their manuscript on a floppy or zip disk, into the mailing material. At the same time the package is mailed, please also send by e-mail a copy of the PDF file of the manuscript to the editorial office.
Online Manuscript Submission: (preferable)
To facilitate speedy and cost-effective submission of abstracts and manuscripts, an online submission and tracking service via Internet is being offered. Once the Editor-in-Chief of the journal has accepted your abstract, we would prefer that you submit your full manuscript online via our online submission service available at www.bentham-mps.org
For online submission, please provide your complete manuscript in the form of a single zipped folder containing all the material (main text, figures/ illustrations, scanned photographs, tables, chemical structures drawn in ChemDraw) as separate files and a PDF version of the entire manuscript with all the figures/ illustrations / tables / chemical structures etc., embedded in the text exactly in the manner as they should appear in printing.
Authors are required to proofread the PDF version of their manuscript before submission. The article will be published exactly as received and the Publishers will not be responsible for any error occurring in the manuscript in this regard.
For online submission of manuscripts, these should be submitted via our online manuscript submission service available at www.bentham-mps.org.
You may, however, still submit your abstracts and manuscripts through conventional surface mail.
Page Charges: No page charges will be levied to authors.
Language Editing: Manuscripts submitted containing many English typographical errors will not be published. Authors from non-English language countries are advised to use the services of our professional language editing department prior to submitting their manuscript to the Journal. Please contact Bentham Publishing Services www.bentham.org/bps for a language editing quote at e-mail: bps@bentham.org stating the total number of words of the article to be edited.
Proofs: Authors are sent page proofs. To avoid delays in publication, proofs should be checked immediately for typographical errors and returned within 48 hours. Authors will be charged for excessive changes made at the page proof stage.
Reprints: Each first named author will receive by e-mail a free copy of their article as a PDF file. The PDF file is a watermarked version of the published article which is exclusively for the author's own use and may not be copied or distributed. Reprints may be ordered from the Publisher prior to publication of the article. First named authors may also order a personal print and online subscription of the journal at 50% off the normal subscription rate by contacting the subscription department at e-mail: subscriptions@bentham.org
Bentham Open Access: Accepted articles can be published online for an immediate free open access for all to view. Open access publishing provides the maximum dissemination of the article to the largest audience. Authors must pay for this service. For more information please contact us at e-mail: openaccess@bentham.org
Reviewing and Promptness of Publication: All papers submitted for publication will be immediately subjected to editorial scrutiny, usually in consultation with members of the Editorial Advisory Board. Every effort will be made to assess the papers quickly. The papers will be typeset and the proofs dispatched to the authors normally within 4 weeks of their acceptance.
Copyright: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism is discovered. By submitting a manuscript the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication. | |
| |
|
|
Editorial Board
Editor-in-Chief:
E. Edmund Kim
Department of Nuclear Medicine
The University of Texas M.D.
Anderson Cancer Center
Box59, 1515 Holcombe Blvd
Houston, TX 77030-4009
USA
Tel: (713) 794-1052
Fax: (713) 794-5456
Email: ekim@di.mdacc.tmc.edu
Editorial Advisory Board:
H.M. Abdel Dayem (St. Vincent's Hosp. & Med. Center, New York, NY, USA)
A.Z. Abuhamad (Eastern Virginia Medical School, Norfolk, VA, USA)
A. Alaivi (Hospital of the University of Pennsylvania, Philadelphia, PA, USA)
E. Alper (Uludag University School of Medicine, Bursa, Turkey)
C. Battaglia (University of Bologna, Bologna, Italy)
J.J. Bax (Leiden University Medical Center, Leiden, The Netherlands)
F. Benard (Ctr. Hosp. Univ. de Sherbrooke, Fleurimont, QC, Canada)
H.J. Biersack (Univ. Hosp. Bonn, Bonn, Germany)
C. Boesch (MR-Center 1, Bern, Switzerland)
L.M. Boxt (Beth Israel Medical Center, New York, NY, USA)
M.W. Brechbiel (ROB,CCR,NCI,NIH, Bethesda, MD, USA)
W. Brenner (University Hospital Hamburg-Eppendorf, Hamburg, Germany)
A. Buck (University Hospital Ulm, Ulm, Germany)
G.M. Bydder (University of California, San Diego, CA, USA)
I. Carrio (Univ. Autonoma Barcelona, Barcelona, Spain)
J.S. Carvalho (Royal Brompton Hospital, London, UK)
R. Chaoui (Humboldt Univ. Charite Med. School, Berlin, Germany)
B.I. Choi (Seoul Natl. Univ. Hospital, Seoul, South Korea)
J.K. Chung (Seoul Natl. Univ. College of Medicine, Seoul, South Korea)
L. Clarke (National Cancer Institute, NIH, Bethesda, MD, USA)
G. Cloutier (University of Montreal, Montreal, Canada)
H.L. Cohen (Stony Brook University School of Medicine, Stony Brook, NY, USA)
A. Cuocolo (University Federico II, Napoli, Italy)
J. Damilakis (University of Crete, Crete, Greece)
C. Divgi (Memorial Sloan-Kettering Cancer Center, New York, NY, USA)
T. Dohi (University of Tokyo, Tokyo, Japan)
W.C. Eckelman (Clinical Center, NIH, Bethesda, MD, USA)
M. Eisenhut (German Cancer Research Center, Heidelberg, Germany)
P.J. Ell (The Middlesex Hospital, London, UK)
R.R. Ernst (ETH Honggerberg HCI Phys. Chem. Lab, Zurich, Switzerland)
M. Estorch (Univ. Autonoma Barcelona, Barcelona, Spain)
F. Fazio (IBFM-CNR University of Milano Bicocca, Milan, Italy)
J. Fettich (University Medical Centre Ljubljana, Ljubljana, Slovenia)
A.J. Fischman (Massachusetts Gen. Hospital, Boston, MA, USA)
I. Fogelman (Guy's Hospital, London, UK)
J. Frahm (Max-Planck-Institut fur Biophysikalische Chemie, Gottingen, Germany)
K.J. Friston (Univ. Coll. London, London, UK)
S. S. Gambhir ( The James H Clark Center, Stanford, USA )
T.C. Gerber (Mayo Clinic Jacksonville, Jacksonville, FL, USA)
R.J. Gillies (Arizona Cancer Center, Tucson, AZ, USA)
A. Gjedde (Aarhus University, Aarhus, Denmark)
G. Glover (Stanford University School of Medicine, Stanford, CA, USA)
D.M. Goldenberg (Garden State Cancer Center, Belleville, NJ, USA)
S.R. Goldstein (New York University School of Medicine, New York, NY, USA)
J.M. Goo (Seoul Natl. Univ. Hospital, Seoul, South Korea)
J.C. Gore (Vanderbilt University, Nashville, TN, USA)
U. Haberkorn (University of Heidelberg, Heidelberg, Germany)
H. Ham (Univ. Ziekenhuis Gent, Ghent, Belgium)
J.A. Helpern (New York University School of Medicine, New York, NY, USA)
B. Hesse (University of Copenhagen, Copenhagen, Denmark)
R.J. Hicks (Peter MacCallum Cancer Centre, Melbourne, Australia)
M. Hoehn (Max-Planck-Institute for Neurological Research, Cologne, Germany)
M. Ichise (Mol. Imaging Branch, NIMH, Bethesda, MD, USA)
M.F. Insana (Univ. Illinois Urbana-Champaign, Urbana, IL, USA)
A.E. Iskandrian (University of Alabama at Birmingham, Birmingham, AL, USA)
E. Jauniaux (Royal Free and University College London, London, UK)
J. Kawai (Kyoto University, Kyoto, Japan)
R. Kawashima (NICHe Tohoku University, Sendai, Japan)
E.E. Kim (Univ. Texas M. D. Anderson Canc. Ctr., Houston, Texas, USA)
T. Kiserud (University of Bergen, Bergen, Norway)
A.L. Klibanov (University of Virginia, Charlottesville, VA, USA)
J. Knuuti (Turku University Central Hospital, Turku, Finland)
S. Kollias (University Hospital of Zurich, Zurich, Switzerland)
L. Kostakoglu (New York Presbyterian Hospital, New York, NY, USA)
F. Kruggel (Max-Planck-Institute of Cognitive Neuroscience, Leipzig, Germany)
K. Kubota (International Medical Center of Japan, Tokyo, Japan)
A. Laghi (Univ. Roma La Sapienza, Rome, Italy)
A.A. Lammertsma (VU University Medical Center, Amsterdam, The Netherlands)
H. Lee (Keimyung Univ. Sch. Med., Taegu, South Korea)
D. Leibfritz (Univ. Bremen Fachbereich Chem 2, Bremen, Germany)
R. Lencioni (University of Pisa, Pisa, Italy)
R.S. Liu (National Yang-Ming Univ. Med. Sch., Taipei, Taiwan)
G. Madeddu (University of Sassari, Sassari, Italy)
M. Makuuchi (Graduate School of Medicine University of Tokyo, Tokyo, Japan)
B. Maraviglia (Univ. Roma La Sapienza, Rome, Italy)
I. R. Mcdougall (Stanford University Medical Center, Stanford, CA, USA)
C. Moonen (Universite Victor Segalen Bordeaux 2, Bordeaux, France)
P.G. Morris (University of. Nottingham , Nottingham, UK)
S.K. Mukherji (University of Michigan Health System, Ann Arbor, MI, USA)
R.V. Mulkern (Childrens Hospital, Harvard Med. Sch., Boston, MA, USA)
R.N. Muller (University of Mons-Hainaut, Mons, Belgium)
D.L. Munz (Charite - Berlin University Medicine, Berlin, Germany)
T. Naidich (Mt. Sinai Medical Ctr., New York, NY, USA)
N.C. Nanda (The University of Alabama at Birmingham, Birmingham, AL, USA)
K. Nicolaides (Univ. London Kings Coll. Hosp., London, UK)
R. Ordidge (Univ. Coll. London, London, UK)
W.J. Oyen (University Medical Center Nijmegen, Nijmegen, The Netherlands)
G. Paganelli (European Institute of Oncology, Milan, Italy)
E. Pauwels (Leiden University Medical Center, Leiden, The Netherlands)
A.M. Peters (Royal Sussex County Hospital, Brighton, UK)
T.M. Peters (University of Western Ontario, London, ON, Canada)
F. Podo (Istituto Superiore di Sanita', Rome, Italy)
G.M. Pohost (Univ. of S. California, Keck Sch. of Med., Los Angeles, CA, USA)
G.J. Price (University of Bath, Bath, UK)
B.E. Rogers (Washington Univ. in St. Louis, St. Louis, MO, USA)
P. Rossi (Univ. Roma La Sapienza, Roma, Italy)
M.D. Rugg (University of California, Irvine, CA, USA)
D.J. Sahn (Oregon Health & Science University, Portland, OR, USA)
H.R. Schelbert (David Geffen Sch. Med. at Univ. of Calif., Los Angeles, CA, USA)
O. Schillaci (University of Roma Tor Vergata, Rome, Italy)
O. Schober (Univ. Klinikum Munster, Munster, Germany)
T.D. Scholz (University of Iowa, Iowa City, IA, USA)
A. Scott (University of Melbourne Austin Hospital, Melbourne, Australia)
W. Sepulveda (Fetal Medicine Center, Clinica Las Condes, Santiago, Chile)
D.M. Sherer (State University of New York, Brooklyn, NY, USA)
A. Signore (Univ. Roma La Sapienza, Roma, Italy)
R.P. Spencer (Univ. Connecticut Health Center, Farmington, CT, USA)
M.G. Stabin (Vanderbilt University, Nashville, TN, USA)
G. Szekely (Swiss Federal Institute of Technology, Zurich, Switzerland)
R. Taillefer (Univ. Montreal Ctr. Hosp., Montreal, Canada)
P. Thompson (UCLA School of Medicine, Los Angeles, CA, USA)
A.W. Toga (UCLA School of Medicine, Los Angeles, CA, USA)
D.W. Townsend (University of Tennessee Medical Center, Knoxville, TN, USA)
B. Trudinger (Univ. Sydney Westmead Hosp., Wentworthville, Australia)
M. Unlu (Gazi University, Ankara, Turkey)
R.F. Uren (RPAH Med. Ctr., Newtown, Australia)
R.A.Valdes Olmos (The Netherlands Cancer Institute, Amsterdam, The Netherlands)
C.H. Van Dyck (Yale University School of Medicine, New Haven, CT, USA)
M.W. Vannier (University of Chicago Medical Center, Chicago, IL, USA)
M.A. Viergever (University Medical Center Utrecht, Utrecht, The Netherlands)
G. Wang (University of Iowa, Iowa City, IA, USA)
L. Wexler (Stanford University School of Medicine, Stanford, CA, USA)
M.C. Ziskin (Temple University School of Medicine, Philadelphia, PA, USA)
|
刊名字顺( Alphabetical List of Journals):
返回页首 